Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

Both steroids effectively promote hair growth for at least 9 months.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Estrogen speeds up hair follicle cell death, causing early hair growth cycle changes, but only if a specific receptor is present.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Thyroid hormone receptors are essential for hair growth and wound healing.

Including androgens in hormone therapy may lower breast cancer risk.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Some people with chronic hair loss may have thyroid autoimmunity.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

The combination therapy was effective and well-tolerated, especially in young patients.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Clascoterone cream could be used for other skin conditions affected by hormones.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Genetics may play a significant role in gender dysphoria.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.